Abstract

Phytochemicals are naturally occurring plant-derived compounds that play significant roles in modulating 
inflammatory processes through diverse cellular and molecular mechanisms. Chronic inflammation contributes to 
the development of diseases such as cardiovascular disorders, rheumatoid arthritis, diabetes, Alzheimer’s disease, 
and cancer. Major classes of anti-inflammatory phytochemicals, including flavonoids, terpenoids, alkaloids, and 
phenolic acids, exert their activity by regulating transcription factors (NF-κB, STAT, MAPK), enzymes (COX-2, 
iNOS, LOX), and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Evidence from preclinical, animal, and human 
studies highlights the therapeutic potential of phytochemicals in reducing inflammation and restoring 
homeostasis. Fruits, vegetables, herbs, and spices are abundant dietary sources, while advanced formulations such 
as nanoparticles and liposomes are improving their solubility and bioavailability. Although promising, challenges 
remain regarding optimal dosage, safety, drug interactions, and regulatory oversight. Future research should 
emphasize clinical trials, novel delivery systems, and emerging phytochemicals with enhanced therapeutic profiles 
to support their integration into conventional and complementary medicine.